Amdocs (DOX) has reported Q2 2026 revenue of US$1,172 million and basic EPS of US$1.29, with the stock trading around US$61.29 as investors weigh the latest set of numbers. The company has seen quarterly revenue move from US$1,110 million in Q1 2025 to US$1,172 million in Q2 2026, while basic EPS has ranged from US$1.34 to US$1.46 in early 2025 to US$1.29 this quarter, setting a clear track record for you to benchmark against the trailing twelve month EPS of US$5.02. With net profit margin nudging higher over the last year, this earnings print keeps the focus squarely on how durable those margins and cash generation look from here.
See our full analysis for Amdocs.With the headline figures on the table, the next step is to see how these results line up with the widely held narratives around Amdocs's growth, risks, and valuation, and where the numbers start to challenge those stories.
See what the community is saying about Amdocs
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Amdocs on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
With the mixed messages from margins, EPS and valuation, sentiment around Amdocs is clearly split, so it makes sense to move fast and test the numbers yourself. To understand why some investors are still optimistic, take a closer look at the 4 key rewards
The recent five year earnings decline, uneven quarterly EPS and reliance on margin expansion indicate that Amdocs is not offering the smooth profit story some investors might prefer.
If you want ideas where the growth thesis already looks more aligned with today’s numbers, start comparing opportunities in the 46 high quality undervalued stocks
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com